ABILIFY® (aripiprazole) Injection for Intramuscular Use is a clear, colorless solution available as a ready-to-use, 9
ABILIFY ® (aripiprazole) Tablets have markings on one side an are available in the strengths and packages listed in Table 32
The drug can also cause more serious effects, including suicidal thoughts, compulsive behaviors and involuntary movement disorders, such as akathisia and tardive dyskinesia
J0401 is a valid 2024 HCPCS code for Injection, aripiprazole, extended release, 1 mg or just “ Inj aripiprazole ext rel 1mg ” for
NDC Code (s): 59148-018-71, 59148-019-71, 59148-045-80, 59148-072-80, view more Packager: Otsuka America Pharmaceutical, Inc
Each injection of ABILIFY MAINTENA must be administered by a healthcare professional only
Coding and billing information If a patient’s health insurer requires that ABILIFY MAINTENA be reimbursed through a buy-and-bill option, Otsuka Patient Support can research and
INDICATIONS